Australia markets closed

Medibio Limited (MEB.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.00800.0000 (0.00%)
At close: 3:59PM AEST
Currency in AUD

Valuation measures

Market cap (intra-day) 514.34M
Enterprise value 39.97M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)12.31
Price/book (mrq)0.80
Enterprise value/revenue 38.56
Enterprise value/EBITDA 7-5.57

Trading information

Stock price history

Beta (5Y monthly) 1.66
52-week change 32.95%
S&P500 52-week change 344.55%
52-week high 30.0170
52-week low 30.0050
50-day moving average 30.0086
200-day moving average 30.0095

Share statistics

Avg vol (3-month) 37.57M
Avg vol (10-day) 34.16M
Shares outstanding 51.79B
Implied shares outstanding 61.79B
Float 1.08B
% held by insiders 116.39%
% held by institutions 113.36%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:100
Last split date 311 Mar 2015

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2020
Most-recent quarter (mrq)31 Dec 2020

Profitability

Profit margin -190.96%
Operating margin (ttm)-172.80%

Management effectiveness

Return on assets (ttm)-8.41%
Return on equity (ttm)-16.66%

Income statement

Revenue (ttm)1.16M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)30.40%
Gross profit (ttm)720.58k
EBITDA -1.79M
Net income avi to common (ttm)-2.22M
Diluted EPS (ttm)-0.0020
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)832.36k
Total cash per share (mrq)0
Total debt (mrq)18.27k
Total debt/equity (mrq)0.14
Current ratio (mrq)0.75
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-1.23M
Levered free cash flow (ttm)-2.44M